Management and Treatment of Hepatitis C: Are There Still Unsolved Problems and Unique Populations?

Direct-acting antivirals (DAA) have revolutionized the treatment of patients with chronic hepatitis C virus (HCV) infection, possibly leading to HCV elimination by 2030 as endorsed by the World Health Organization (WHO). However, some patients belonging to the so-called unique or special populations...

Descripción completa

Detalles Bibliográficos
Autores principales: Solitano, Virginia, Plaz Torres, Maria Corina, Pugliese, Nicola, Aghemo, Alessio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228389/
https://www.ncbi.nlm.nih.gov/pubmed/34205966
http://dx.doi.org/10.3390/v13061048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228389/
https://www.ncbi.nlm.nih.gov/pubmed/34205966
http://dx.doi.org/10.3390/v13061048

Ejemplares similares